Hispanic and Latino-founded YC companies | Y Combinator
Estimating deaths averted and cost per life saved by scaling up mRNA COVID-19 vaccination in low-income and lower-middle-income countries in the COVID-19 Omicron variant era: a modelling study | BMJ Open
A Stress Test for America's New COVID Plan Is Coming - The Atlantic
Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis - The Lancet Global Health
Our People - Blackstone
Future Directions for Cost-effectiveness Analyses in Health and Medicine
39th Annual Meeting of the Society for Medical Decision Making Pittsburgh, Pennsylvania, October 22-25, 2017, 2018
Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis. - Abstract - Europe PMC
WhatsApp Surveys: An Innovative and Low-Cost Solution for Remote Data Collection | Innovations for Poverty Action
Joshua Salomon (@SalomonJA) / Twitter
40th Annual Meeting of the Society for Medical Decision Making Montréal, Québec, Canada, October 13–17, 2018, 2019
WHO GUIDE TO COST-EFFECTIVENESS ANALYSIS
NIA-Funded Active Alzheimer's and Related Dementias Clinical Trials and Studies | National Institute on Aging
Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis - The Lancet Global Health
FSI | SHP - Joshua Salomon
When cost-effective interventions are unaffordable: Integrating cost- effectiveness and budget impact in priority setting for global health programs | PLOS Medicine
Adaptive Policies to Balance Health Benefits and Economic Costs of Physical Distancing Interventions during the COVID-19 Pandemic - Reza Yaesoubi, Joshua Havumaki, Melanie H. Chitwood, Nicolas A. Menzies, Gregg Gonsalves, Joshua A.
Front Matter | Valuing Health for Regulatory Cost-Effectiveness Analysis |The National Academies Press
PDF) When cost-effective interventions are unaffordable: Integrating cost- effectiveness and budget impact in priority setting for global health programs
PDF) Cost-Effectiveness and Cost Thresholds of Generic and Brand Drugs in a National Chronic Hepatitis B Treatment Program in China
FSI | SHP - Joshua Salomon
FSI | SHP - Joshua Salomon
Joshua Salomon (@SalomonJA) / Twitter
Balancing health and financial protection in health benefit package design - Lofgren - - Health Economics - Wiley Online Library
Joshua Salomon – Prevention Policy Modeling Lab
